Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this analysis of two trials, baricitinib showed eyebrow and eyelash regrowth in severe alopecia areata patients with greater than 20% scalp hair loss at Week 36, compared to placebo.

This case study highlights that even professional eyebrow tinting can lead to chemical burns, and increasing consumer awareness is crucial as its popularity grows and unregulated products become more common.

In this study, baricitinib treatment led to significant regrowth of scalp, eyebrow, and eyelash hair in alopecia areata patients compared to placebo, with higher effectiveness seen at the 4-mg dose.

This study observed that consuming 50g of cheonggukjang daily for 3 months improved eyebrow length, thickness, and reduced damage in middle-aged women compared to controls, although the number of eyebrows did not change.

Using three-hair grafts from the back of the head for eyebrow transplantation offers a natural look and reduces scarring.

In this study, a gel containing extracts from Coffea arabica and Larrea divaricata was found to significantly thicken eyebrows and eyelashes in most premenopausal and postmenopausal women, without causing adverse effects, but showed no statistical difference from a placebo in overall hair growth.

OMICS International promotes scientific research and knowledge sharing by publishing peer-reviewed articles in various fields and organizing international scientific conferences.

This study presented a case where eyebrow hair follicles transplanted in a patient undergoing radiotherapy survived, resulting in a satisfactory and symmetrical appearance.

This case report describes a patient who experienced recalcitrant folliculitis leading to atrophic scarring following eyebrow transplantation.

This correspondence discusses eyebrow alopecia in the context of centrofacial trichoblastomatosis and reports no new clinical findings.

This study found that a straightforward technique for single hair grafting achieved a 96% success rate in eyebrow transplantations with cosmetically pleasing outcomes and no complications.

This review article from the examined literature highlights the shift in eyebrow reconstruction techniques from traditional methods to minimally invasive and regenerative approaches, evaluating their principles, outcomes, and challenges to inform future clinical practices.

JAK inhibitors help regrow eyebrow and eyelash hair and improve anxiety and depression in some alopecia areata patients.

This study explored professionals' insights on eyebrow transplantation, finding that while the procedure can enhance appearance and confidence, it also carries risks such as potential complications and costs, emphasizing the need for thorough pre-operative consultations.

The measures for eyebrow and eyelash hair loss in severe Alopecia Areata are reliable and useful for clinical trials.

This study presents a new automated computer vision system to objectively measure periocular hair density changes in breast cancer patients undergoing chemotherapy, demonstrating high precision in tracking individual changes and potential as a reliable tool for future clinical trials.

This prospective study observed that low-dose oral minoxidil improved anterior hairline and eyebrow coverage in adult women with frontal fibrosing alopecia and was generally well-tolerated.

This review discusses how permanent micropigmentation can restore eyebrow appearance and potentially improve psychosocial well-being in cancer survivors experiencing alopecia after chemotherapy, but it reports no new clinical results.

This study found that eyebrow follicles, as opposed to buccal swabs or nails, are the most reliable tissue for post-HSCT germline genetic testing due to lower donor DNA contamination.

In this study, the application of hibiscus hair oil combined with Gua-sha improved eyebrow hair rejuvenation more effectively than hibiscus oil alone in female participants, enhancing microcirculation and aesthetic features after 30 days.

This study reported that applying stem cell serum daily resulted in eyebrow hair regrowth in a patient with chronic secondary cicatricial alopecia, and prevented hair loss in another patient with acute eyebrow trauma, suggesting it as a noninvasive treatment alternative.

This case report describes how a 23-year-old woman experienced eyebrow thinning and hair loss linked to cosmetic use, with diagnostic tests confirming follicular damage. Discontinuing the product led to eyebrow regrowth, highlighting potential risks from cosmetics and the value of non-invasive diagnostics for evaluation.

This review highlights that while permanent eyebrow correction via micropigmentation may help restore visual appearance for patients experiencing eyebrow loss post-chemotherapy, the psychoemotional benefits of this procedure remain unclear, demonstrating a need for further research into its impact on quality of life.

This study found that eyebrow mesotherapy with a growth factor-based serum improved eyebrow width, length, density, and psychosocial outcomes such as social engagement, quality of life, confidence, and mood in individuals with sparse or weakened eyebrows.

In this study on adolescents with severe alopecia areata, baricitinib treatment showed effective scalp, eyebrow, and eyelash regrowth after 52 weeks, benefiting both responders and partial or non-responders, potentially reducing the psychosocial impact of the disease.

In this case report, researchers documented a young girl's eyebrow hair loss attributed to trichotillosis influenced by observing Jain monks' ritualistic hair plucking, highlighting the role of cultural practices in shaping compulsive behaviors.

This study reports that a novel eyelash transplantation method using chalazion forceps effectively thickens and enhances eyelashes by precisely placing transplanted hairs in a narrow recipient area, with approximately 85-92% of transplanted lashes expected to grow within 12 months.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

This study observed that omalizumab may induce alopecia, particularly in females aged 18-60, though establishing a direct cause-effect link remains challenging. Alopecia areata was noted as a possible uncommon, yet transient, hair loss type associated with omalizumab.